Cardiff Lexington Corporation (CDIX)
OTCMKTS · Delayed Price · Currency is USD
0.0050
-0.0073 (-59.35%)
At close: Nov 17, 2026
Cardiff Lexington Revenue
Cardiff Lexington had revenue of $1.91M in the quarter ending September 30, 2026, a decrease of -37.48%. This brings the company's total for the last twelve months to $9.07M, down -23.71% year-over-year. In the year 2025, Cardiff Lexington had annual revenue of $11.54M with 39.48% growth. That makes Cardiff Lexington the 37,836th largest company in the world by revenue and 4,968th in the United States.
Revenue (ttm)
9.07M
Revenue Growth
-23.71%
P/S Ratio
0.01
Revenue / Employee
533.31K
Employees
18
Market Cap
110.24K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.54M | 3.27M | 39.48% |
| Dec 31, 2024 | 8.27M | -3.58M | -30.23% |
| Dec 31, 2023 | 11.85M | 1.16M | 10.85% |
| Dec 31, 2022 | 10.69M | 814.14K | 8.24% |
| Dec 31, 2021 | 9.88M | 6.43M | 186.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aesthetic Medical International Holdings Group | 103.35M |
| FOXO Technologies | 21.32M |
| Novo Integrated Sciences | 13.29M |
| Healthcare Solutions Management Group | 9.25M |
| CYIOS | 1.49M |
| MedSmart Group | 726.81K |
| Dental Patient Care America | 475.52K |
| Primemd | 69.98K |
Cardiff Lexington News
- 2 days ago - Cardiff Lexington Earnings Call Transcript: Q3 2026 - Transcripts
- 2 days ago - Cardiff Lexington Quarterly report: Q3 2026 - Filings
- 2 days ago - Cardiff Lexington Earnings release: Q3 2026 - Filings
- 2 days ago - Cardiff Lexington Slides: Q3 2026 - Filings
- 7 weeks ago - Cardiff Lexington Corporation Announces Letter of Intent for Proposed Acquisition of Leading Musculoskeletal Healthcare Platform - Accesswire
- 3 months ago - Cardiff Lexington Earnings Call Transcript: Q2 2026 - Transcripts
- 3 months ago - Cardiff Lexington Earnings release: Q2 2026 - Filings
- 3 months ago - Cardiff Lexington Slides: Q2 2026 - Filings